Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 6/2017

01-12-2017 | Research Article

Patients’ knowledge on oral anticoagulant treatment in Hungary

Authors: Reka Viola, Helga Fekete, Ildiko Csoka

Published in: International Journal of Clinical Pharmacy | Issue 6/2017

Login to get access

Abstract

Background A key element for an effective and safe oral anticoagulant treatment (OAT) is to have the relevant information delivered to patients in an easy-to-understand way and thus have them apply this knowledge in their own therapy. Objective To assess knowledge about OAT, reveal knowledge gaps and identify at-risk patients in terms of limited knowledge about their anticoagulant therapy. Setting Community pharmacies in Hungary. Methods This descriptive cross-sectional study used a structured, validated, self-developed questionnaire to assess patients’ knowledge about OAT. Scores were calculated on each domain and the association between knowledge and patients’ or treatment characteristics were analysed. Responses in all domains were assessed to identify at-risk patients and knowledge gaps. Main outcome measures Knowledge and knowledge gaps on OAT, and risk factors for limited knowledge. Results The questionnaire developed based on four validated questionnaires passed the field test and had a good internal consistency (Cronbach α = 0.795). Our full patient population (N = 427) had a mean percentage score of 59.39 (29.7% good, 41.2% average, 29.0% poor knowledge on OAT). Poor knowledge level was found to significantly correlate with advanced age (> 75 years), lower education, diagnosis of atrial fibrillation, and unawareness of the indication of OAT. The lowest frequency of correct answers regarded the questions on drug interactions (10.2%) and diet (11.4%). Pharmacists were infrequently indicated as the healthcare professionals to share information with regarding OAT (12.7%). Conclusion Findings of our study offer a valuable insight into the required directions of developing new strategies for patient education to improve knowledge on the treatment with oral anticoagulants.
Literature
1.
go back to reference Goldhaber SZ. Venous thromboembolism: epidemiology and magnitude of the problem. Best Pract Res Clin Haematol. 2012;25(3):235–42.CrossRefPubMed Goldhaber SZ. Venous thromboembolism: epidemiology and magnitude of the problem. Best Pract Res Clin Haematol. 2012;25(3):235–42.CrossRefPubMed
2.
go back to reference Feigin VL, Krishnamurthi RV, Parmar P, Norrving B, Mensah GA, Bennett DA, et al. Update the global burden of ischaemic and hemorrhagic stroke in 1990–2013: the GBD 2013 study. Neuroepidemiology. 2015;45(3):161–76.CrossRefPubMedPubMedCentral Feigin VL, Krishnamurthi RV, Parmar P, Norrving B, Mensah GA, Bennett DA, et al. Update the global burden of ischaemic and hemorrhagic stroke in 1990–2013: the GBD 2013 study. Neuroepidemiology. 2015;45(3):161–76.CrossRefPubMedPubMedCentral
3.
go back to reference Bajorek B, Magin PJ, Hilmer S, Krass I. Utilization of antithrombotic therapy for stoke prevention in atrial fibrillation: a cross-sectional baseline analysis in general practice. J Clin Pharm Ther. 2016;41(4):432–40.CrossRefPubMed Bajorek B, Magin PJ, Hilmer S, Krass I. Utilization of antithrombotic therapy for stoke prevention in atrial fibrillation: a cross-sectional baseline analysis in general practice. J Clin Pharm Ther. 2016;41(4):432–40.CrossRefPubMed
4.
go back to reference Hanemaaijer S, Sodihardjo F, Horikx A, Wensing M, De Smet PA, Bouvy ML, et al. Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands. Int J Clin Pharm. 2015;37(6):1128–35.CrossRefPubMedPubMedCentral Hanemaaijer S, Sodihardjo F, Horikx A, Wensing M, De Smet PA, Bouvy ML, et al. Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands. Int J Clin Pharm. 2015;37(6):1128–35.CrossRefPubMedPubMedCentral
5.
go back to reference Hernandez Madrid A, Potpara TS, Dagres N, Chen J, Larsen TB, Estner H, et al. Diffrences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European Heart Rhythm Association. Europace. 2016;18(3):463–7.CrossRefPubMed Hernandez Madrid A, Potpara TS, Dagres N, Chen J, Larsen TB, Estner H, et al. Diffrences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European Heart Rhythm Association. Europace. 2016;18(3):463–7.CrossRefPubMed
6.
go back to reference Rodriguez RA, Carrier M, Wells PS. Non-adherence to new oral anticoagulants: a reason for concern during long-term anticoagulation? J Thromb Haemost. 2013;11(2):390–4.CrossRefPubMed Rodriguez RA, Carrier M, Wells PS. Non-adherence to new oral anticoagulants: a reason for concern during long-term anticoagulation? J Thromb Haemost. 2013;11(2):390–4.CrossRefPubMed
7.
go back to reference Yao X, Abraham NS, Alexander GC, Crown W, Montori V, Sangaralingham LR, et al. Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation. J Am Heart Assoc. 2016;5(2):e003074.CrossRefPubMedPubMedCentral Yao X, Abraham NS, Alexander GC, Crown W, Montori V, Sangaralingham LR, et al. Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation. J Am Heart Assoc. 2016;5(2):e003074.CrossRefPubMedPubMedCentral
8.
go back to reference Kagansky N, Knobler H, Rimon E, Ozer Z, Levy S. Safety of anticoagulation therapy in well-informed older patients. Arch Intern Med. 2004;164(18):2044–50.CrossRefPubMed Kagansky N, Knobler H, Rimon E, Ozer Z, Levy S. Safety of anticoagulation therapy in well-informed older patients. Arch Intern Med. 2004;164(18):2044–50.CrossRefPubMed
9.
go back to reference Ewen S, Rettig-Ewen V, Mahfoud F, Boehm M, Laufs U. Drug adherence in patients taking oral anticoagulation therapy. Clin Res Cardiol. 2014;103(3):173–82.CrossRefPubMed Ewen S, Rettig-Ewen V, Mahfoud F, Boehm M, Laufs U. Drug adherence in patients taking oral anticoagulation therapy. Clin Res Cardiol. 2014;103(3):173–82.CrossRefPubMed
10.
go back to reference Wang Y, Kong MC, Lee LH, Ng HJ, Ko Y. Knowledge, satisfaction, and concerns regarding warfarin therapy and their association with warfarin adherence and anticoagulation control. Thromb Res. 2014;133(4):550–4.CrossRefPubMed Wang Y, Kong MC, Lee LH, Ng HJ, Ko Y. Knowledge, satisfaction, and concerns regarding warfarin therapy and their association with warfarin adherence and anticoagulation control. Thromb Res. 2014;133(4):550–4.CrossRefPubMed
11.
go back to reference Borg Xuereb C, Shaw RL, Lane DA. Patients’ and health professionals’ views and experiences of atrial fibrillation and oral-anticoagulant therapy. A qualitative meta-synthesis. Patient Educ Couns. 2012;88(2):330–7.CrossRefPubMed Borg Xuereb C, Shaw RL, Lane DA. Patients’ and health professionals’ views and experiences of atrial fibrillation and oral-anticoagulant therapy. A qualitative meta-synthesis. Patient Educ Couns. 2012;88(2):330–7.CrossRefPubMed
12.
go back to reference Kneeland PP, Fang MC. Current issues in patient adherence and persistence. Focus on anticoagulants for the treatment and prevention of thromboembolism. Patient Prefer Adherence. 2010;4:51–60.PubMedPubMedCentral Kneeland PP, Fang MC. Current issues in patient adherence and persistence. Focus on anticoagulants for the treatment and prevention of thromboembolism. Patient Prefer Adherence. 2010;4:51–60.PubMedPubMedCentral
13.
go back to reference Hedegaard U, Kjeldsen LJ, Pottegard A, Bak S, Hallas J. Multifaceted intervention including motivational interviewing to support medication adherence after stroke/transient ischemic attack: a randomized trial. Cerebrovasc Dis Extra. 2014;4(3):221–34.CrossRefPubMedPubMedCentral Hedegaard U, Kjeldsen LJ, Pottegard A, Bak S, Hallas J. Multifaceted intervention including motivational interviewing to support medication adherence after stroke/transient ischemic attack: a randomized trial. Cerebrovasc Dis Extra. 2014;4(3):221–34.CrossRefPubMedPubMedCentral
14.
go back to reference Varnai R, Vegh M, Poto L, Nagy L. Level of knowledge among patients treated with oral anticoagulant. Orv Hetil. 2008;149(43):2047–51.CrossRefPubMed Varnai R, Vegh M, Poto L, Nagy L. Level of knowledge among patients treated with oral anticoagulant. Orv Hetil. 2008;149(43):2047–51.CrossRefPubMed
15.
go back to reference Alphonsa A, Sharma K, Sharma G, Bhatia R. Knowledge regarding oral anticoagulation therapy among patients with stroke and those at high risk of thromboembolic events. J Stroke Cerebrovasc Dis. 2015;24(3):668–72.CrossRefPubMed Alphonsa A, Sharma K, Sharma G, Bhatia R. Knowledge regarding oral anticoagulation therapy among patients with stroke and those at high risk of thromboembolic events. J Stroke Cerebrovasc Dis. 2015;24(3):668–72.CrossRefPubMed
16.
go back to reference Zeolla MM, Brodeur MR, Dominelli A, Haines ST, Allie ND. Development and validation of an instrument to determine patient knowledge. The oral anticoagulation knowledge test. Ann Pharmacother. 2006;40(4):633–8.CrossRefPubMed Zeolla MM, Brodeur MR, Dominelli A, Haines ST, Allie ND. Development and validation of an instrument to determine patient knowledge. The oral anticoagulation knowledge test. Ann Pharmacother. 2006;40(4):633–8.CrossRefPubMed
17.
go back to reference Briggs AL, Jackson TR, Bruce S, Shapiro NL. The development and performance validation of a tool to assess patient anticoagulation knowledge. Res Soc Adm Pharm. 2005;1(1):40–59.CrossRef Briggs AL, Jackson TR, Bruce S, Shapiro NL. The development and performance validation of a tool to assess patient anticoagulation knowledge. Res Soc Adm Pharm. 2005;1(1):40–59.CrossRef
18.
go back to reference Chenot JF, Hua TC, Abed A, Schnider-Rudt H, Friede T, Schnider S, Vomfelde SV. Safety relevant knowledge of orally anticoagulated patients without self-monitoring: a baseline survey in primary care. BMC Fam Pract. 2014;25(15):104.CrossRef Chenot JF, Hua TC, Abed A, Schnider-Rudt H, Friede T, Schnider S, Vomfelde SV. Safety relevant knowledge of orally anticoagulated patients without self-monitoring: a baseline survey in primary care. BMC Fam Pract. 2014;25(15):104.CrossRef
19.
go back to reference Shrestha S, Sapkota B, Kumpakha A, Acharya U, Sharma R. Evaluation of patients’ knowledge on warfarin in outpatient pharmacy of a tertiary care cardiac center. BMC Res Notes. 2015;10(8):429–33.CrossRef Shrestha S, Sapkota B, Kumpakha A, Acharya U, Sharma R. Evaluation of patients’ knowledge on warfarin in outpatient pharmacy of a tertiary care cardiac center. BMC Res Notes. 2015;10(8):429–33.CrossRef
20.
go back to reference Fang MC, Machtinger EL, Wang F, Schillinger D. Health literacy and anticoagulation-related outcomes among patients taking warfarin. J Gen Intern Med. 2006;21(8):841–6.CrossRefPubMedPubMedCentral Fang MC, Machtinger EL, Wang F, Schillinger D. Health literacy and anticoagulation-related outcomes among patients taking warfarin. J Gen Intern Med. 2006;21(8):841–6.CrossRefPubMedPubMedCentral
21.
go back to reference Mavri A, Ostasevski Fernandez N, Kramaric A, Kosmelj K. New educational approach for patients on warfarin improves knowledge and therapy control. Wien Klin Wochenschr. 2015;127(11–12):472–6.CrossRefPubMed Mavri A, Ostasevski Fernandez N, Kramaric A, Kosmelj K. New educational approach for patients on warfarin improves knowledge and therapy control. Wien Klin Wochenschr. 2015;127(11–12):472–6.CrossRefPubMed
22.
go back to reference Mayet AY. Association between oral anticoagulation knowledge, anticoagulation control, and demographic characteristics of patients attending an anticoagulation clinic in Saudi Arabia. A cross-sectional prospective evaluation. Trop J Pharm Res. 2015;14(7):285–91.CrossRef Mayet AY. Association between oral anticoagulation knowledge, anticoagulation control, and demographic characteristics of patients attending an anticoagulation clinic in Saudi Arabia. A cross-sectional prospective evaluation. Trop J Pharm Res. 2015;14(7):285–91.CrossRef
23.
go back to reference Whelan W, Sahm L. Assessment of health literacy in patients receiving warfarin anticoagulation therapy and correlation of results with anticoagulant control. Eur J Hosp Pharm. 2012;19(2):249.CrossRef Whelan W, Sahm L. Assessment of health literacy in patients receiving warfarin anticoagulation therapy and correlation of results with anticoagulant control. Eur J Hosp Pharm. 2012;19(2):249.CrossRef
24.
go back to reference Tang EO, Lai CS, Lee KK, Wong RS, Cheng G, Chan TY. Relationship between patients’ warfarin knowledge and anticoagulation control. Ann Pharmacother. 2003;37(1):34–9.CrossRefPubMed Tang EO, Lai CS, Lee KK, Wong RS, Cheng G, Chan TY. Relationship between patients’ warfarin knowledge and anticoagulation control. Ann Pharmacother. 2003;37(1):34–9.CrossRefPubMed
26.
go back to reference Hasan SS, Shamala R, Syed IA, Basariah N, Chong DW, Mei TK, Chin OH. Factors affecting warfarin-related knowledge and INR control of patients attending physician- and pharmacist-managed anticoagulation clinics. J Pharm Pract. 2011;24(5):485–93.CrossRefPubMed Hasan SS, Shamala R, Syed IA, Basariah N, Chong DW, Mei TK, Chin OH. Factors affecting warfarin-related knowledge and INR control of patients attending physician- and pharmacist-managed anticoagulation clinics. J Pharm Pract. 2011;24(5):485–93.CrossRefPubMed
28.
go back to reference Fang MC, Panguluri P, Machtinger EL, Schillinger D. Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: implications for health communication. Patient Educ Couns. 2009;75(3):403–10.CrossRefPubMedPubMedCentral Fang MC, Panguluri P, Machtinger EL, Schillinger D. Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: implications for health communication. Patient Educ Couns. 2009;75(3):403–10.CrossRefPubMedPubMedCentral
Metadata
Title
Patients’ knowledge on oral anticoagulant treatment in Hungary
Authors
Reka Viola
Helga Fekete
Ildiko Csoka
Publication date
01-12-2017
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 6/2017
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-017-0544-1

Other articles of this Issue 6/2017

International Journal of Clinical Pharmacy 6/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.